BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, February 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 31, 2007
View Archived Issues
Crucell's West Nile vaccine meets phase I study endpoints
Read More
Nasalfent begins phase III program in breakthrough cancer pain
Read More
New phase I/II trial under way for TNFerade in head and neck cancer
Read More
IND acceptance for SPC/ENZ-2968 triggers milestone payment
Read More
Aranesp increases risk of death in cancer patients not receiving treatment
Read More
Novel inhibitor of protein-protein interactions in the Wnt pathway suppresses tumor growth in vivo
Read More
Oral entry inhibitor SP-10 shows antiviral activity in HCV
Read More
VRX-480773: a novel NNRTI with activity against efavirenz-resistant HIV
Read More
LAB International closes PharmaForm acquisition
Read More
Recent patents describe new agents for musculoskeletal and connective tissue disorders
Read More
Recent patents report novel therapeutic agents for HIV infection
Read More
New agents for schizophrenia and depression disclosed in recent patents
Read More
Targeting orexin receptors may be useful to treat sleep disorders
Read More
Yaz approved to treat acne in women
Read More
Promising phase II findings for INGN-225 in small cell lung cancer
Read More
GSK files prepandemic influenza vaccine in E.U.
Read More
Sunesis to advance phase II SCLC study of SNS-595 into second stage
Read More
Phase II trial explores topical AVR-118 as wound healing agent
Read More
RPI-78M begins phase IIb study in adrenomyeloneuropathy
Read More
Intravenous administration approved for Vidaza
Read More
Phase II enrollment open for glufosfamide in platinum-resistant ovarian cancer
Read More
Preliminary findings from phase IIb asthma study of IPL-512,602
Read More
DiabeCell cleared for Russian study in type 1 diabetes
Read More
Lexicon changes name, refocuses operations on drug discovery and development
Read More
Mirena approved in Japan
Read More
Pariet approved in Japan for H. pylori eradication
Read More
Relenza approved in Japan for influenza prophylaxis
Read More
